Iceland vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB
Iceland
100.0%
in 2024
Western Pacific (WHO region)
89.0%
in 2024
Iceland rank
1st
Western Pacific (WHO region) rank
2nd
New cases tested for RR-/MDR-TB over time
- Iceland
- Western Pacific (WHO region)
How they compare
Iceland currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.
That makes Iceland's figure about 1.1 times Western Pacific (WHO region)'s.
The two have swapped places 2 times across 17 shared years of data; in 2005 it was Iceland ahead.
Iceland ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
Across the 3 decades both report, Iceland averaged higher in 2 and Western Pacific (WHO region) in 1.
Head to head by decade
| Decade | Iceland | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 0.9% | 99.1% | Iceland |
| 2010s | 92.2% | 23.6% | 68.6% | Iceland |
| 2020s | 50.0% | 88.0% | 38.0% | Western Pacific (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Iceland or Western Pacific (WHO region)?
- Iceland, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Iceland and Western Pacific (WHO region)?
- 11.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Western Pacific (WHO region)?
- 17 years are reported by both, from 2005 to 2024.
- How do Iceland and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Iceland ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.